Cargando…
In situ Metabolomics of Metabolic Reprogramming Involved in a Mouse Model of Type 2 Diabetic Kidney Disease
The in situ metabolic profiling of the kidney is crucial to investigate the complex metabolic reprogramming underlying diabetic kidney disease (DKD) and to allow exploration of potential metabolic targets to improve kidney function. However, as the kidney is a highly heterogeneous organ, traditional...
Autores principales: | Linnan, Bai, Yanzhe, Wang, Ling, Zhang, Yuyuan, Liu, Sijia, Chen, Xinmiao, Xie, Fengqin, Li, Xiaoxia, Wang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670437/ https://www.ncbi.nlm.nih.gov/pubmed/34916961 http://dx.doi.org/10.3389/fphys.2021.779683 |
Ejemplares similares
-
The protective mechanism of Dehydromiltirone in diabetic kidney disease is revealed through network pharmacology and experimental validation
por: Wang, Yanzhe, et al.
Publicado: (2023) -
Investigating the effect of dehydromiltirone on septic AKI using a network pharmacology method, molecular docking, and experimental validation
por: Chen, Sijia, et al.
Publicado: (2023) -
Metabolic Reprogramming of Mouse Bone Marrow Derived Macrophages Following Erythrophagocytosis
por: Catala, Alexis, et al.
Publicado: (2020) -
Vitamin D-VDR (vitamin D receptor) alleviates glucose metabolism reprogramming in lipopolysaccharide-induced acute kidney injury
por: Dai, Qing, et al.
Publicado: (2023) -
Lactobacillus brevis Alleviates DSS-Induced Colitis by Reprograming Intestinal Microbiota and Influencing Serum Metabolome in Murine Model
por: Ding, Sujuan, et al.
Publicado: (2019)